J Clin Lipidol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Long Term Lipoprotein Apheresis Can Reduce Cardiovascular Events for Patients with Elevated Lp(a)

Long Term Lipoprotein Apheresis Can Reduce Cardiovascular Events for Patients with Elevated Lp(a)
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

J clin lipidolFriederike schumannNational lipid associationStandard deviationNext step

5 Tips to Manage Heart Health After a Heart Attack

5 Tips to Manage Heart Health After a Heart Attack
wpbf.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wpbf.com Daily Mail and Mail on Sunday newspapers.

United statesJ clin lipidolColl cardiolNorman leporNational lipid associationCommittee for practice guidelinesVascular healthNovartis pharmaceuticals corporationAmerican heart associationAuthors task force membersAlcohol res healthNational cardiac societiesNovartis pharmaceuticalsAmen betweenClinical perspectiveNational lipid

Alirocumab Reduces LDL-C in Pediatric Heterozygous Familial Hypercholesterolemia

Alirocumab every 2 or 4 weeks significantly reduced LDL-C in pediatric patients with inadequately controlled heterozygous familial hypercholesterolemia.

Sao pauloRauld santosLinkedin rauld santosJ clin lipidolColl cardiolUniversity of sao paulo medical school hospitalAmerican college of cardiology heart associationLipid clinic heart instituteSao paulo medical schoolAmerican heart associationRandomized clinicalAmerican collegeAmerican heart association task forceClinical practice

The Role of Specialty Pharmacists in Overcoming Barriers Associated With PCSK9 Inhibitors

Specialty pharmacists play an important role in dispensing PCSK9 inhibitors and serve as a valuable source of assistance and education for patients.

United statesJ clin lipidolColl cardiolClin lipidolAmgen incAmerican heart associationNational lipid associationAmerican college of cardiology heart associationAmerican college of cardiologyVasc health risk managHealth aff millwoodHeart associationAmerican collegeBlood cholesterolVasc health riskNational lipid

Novartis Pharma AG: New long-term Leqvio (inclisiran) data from Novartis show sustained efficacy and safety over four years

Results from ORION-3 open-label trial show twice-yearly Leqvio(inclisiran), as a complement to statin therapy, provides effective and sustained reductions in low-density lipoprotein cholesterol (LDL-C)

City ofUnited kingdomUnited statesNicole zinsli sommColl cardiolNorman leporLos angelesSamir shahParag mahantiRichard jarvisKausik rayIsabella zinckDavid soergelMichael meoSatoshi sugimotoJ clin lipidol